P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

Aalok Agrawal, Senior Vice-President, P&G Health (Asia Pacific, India, Middle East & Africa) said, "An estimated 1 in 2 Diabetics2 and 1 in 103 Pre-diabetics suffer from Peripheral Neuropathy, while Vitamin B Deficiency affects the quality of life of ~19% of all people with diabetes,4,5. A key barrier we have recognized is that pre-diabetic and diabetic patients are often unaware of their symptoms, which leads to delay in seeking treatment, and a resultant impact on quality of life. The #KnowtheSigns campaign is a step change in the approach towards health awareness, as for the first time, we have leveraged Artificial Intelligence (AI) to make the invisible condition of PN & Vitamin B deficiency visible and more relatable to consumers. We hope to help people understand the condition by shedding light on daily struggles and symptoms. Not many people are aware that early diagnosis can help enable better treatment outcomes and better quality of life, and damaged nerves can be regenerated…
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Aalok Agrawal, Senior Vice-President, P&G Health (Asia Pacific, India, Middle East & Africa) said, "An estimated 1 in 2 Diabetics2 and 1 in 103 Pre-diabetics suffer from Peripheral Neuropathy, while Vitamin B Deficiency affects the quality of life of ~19% of all people with diabetes,4,5. A key barrier we have recognized is that pre-diabetic and diabetic patients are often unaware of their symptoms, which leads to delay in seeking treatment, and a resultant impact on quality of life. The #KnowtheSigns campaign is a step change in the approach towards health awareness, as for the first time, we have leveraged Artificial Intelligence (AI) to make the invisible condition of PN & Vitamin B deficiency visible and more relatable to consumers. We hope to help people understand the condition by shedding light on daily struggles and symptoms. Not many people are aware that early diagnosis can help enable better treatment outcomes and better quality of life, and damaged nerves can be regenerated if nerve damage has not progressed too far."

The #KnowtheSigns campaign includes an online and offline 'See what they feel' Photo Exhibit, wherein real-life patient experiences have been brought to life using AI to help consumers identify early signs of nerve damage and vitamin B deficiency. Further, a simulated 'Touch Room' - virtual and on-ground - with altered everyday items highlights the impact on quality of life of patients. A free Digital Self-Screening tool provides consumers a simple and quick self-assessment to check for symptoms and understand when to contact a healthcare practitioner.

"We will also be organizing #KnowtheSigns scientific events with leading Health Experts to create awareness on the importance of identifying signs of Peripheral Neuropathy and Vitamin B Deficiency in patients, diagnosing high-risk patients, and latest guidelines in management including the role of high dose B Vitamins in treatment."  Aalok Agrawal added.

#KnowtheSigns will be live all of November across on-ground and digital touchpoints in Philippines, Indonesia, India, Singapore, Malaysia, Thailand, UAE, Saudi Arabia, and South Africa in collaboration with healthcare professionals, medical organizations, influencers, partners, consumers, and patients. For more information on the campaign, please write to our media contacts.

Disclaimer: Indications of Neurobion may differ in different countries, please check with your local healthcare professionals for more information.

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

About P&G Health:
P&G Health, the health care division of P&G company, drives consumer-centric innovation to empower our consumers to live healthier, and more vibrant lives. The P&G Health portfolio includes leading brands in Respiratory with Vicks® and Nasivin®, Pregnancy with Femibion® and Clearblue®, Oral Care with Crest® and Oral-B®, Vitamins and Minerals Supplementation with Bion3®, Seven Seas®, Evion® and Sangobion®, Digestive wellness with Metamucil®, Prilosec OTC®, Pepto Bismol® and Align®, Nerve Care with Neurobion® and Pain Relief with Dolo-Neurobion®.

About Procter & Gamble:
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.

References:
1.     Landmann G. Ars Medici. 2013;1: 18-21
2.     Kumar S, et al. Laser Therapy 2016;25: 141–144
3.     Ziegler D et al. Neuropathy in prediabetes. Diabetes Metab Res Rev. 2023
4.     Nix WA et al. Diabetes Res Clin Pract 2015; 107:157–165.
5.     Adaikalakoteswari A et al. Diabetes Res Clin Pract 2012; 95:415–424.

Photo - https://mma.prnewswire.com/media/2260998/Image_credit_P_G_Health.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/pg-health-commemorates-world-diabetes-day-2023-with-innovative-ai-based-experiential-campaign-knowthesigns-301972794.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;